Total planned funding: $183,559,492
Allocations
Countries/Regions
India | $183,559,492 |
Organizational Types
Unknown | $83,239,387 |
NGO | $49,566,046 |
Own Agency | $26,760,751 |
University | $11,500,000 |
Multi-lateral Agency | $3,966,808 |
Implementing Agency | $3,100,000 |
Private Contractor | $2,409,000 |
FBO | $1,600,000 |
Host Country Government Agency | $1,010,200 |
Other USG Agency | $407,300 |
Program Areas
Governance and Systems | $76,617,716 |
Prevention | $42,635,477 |
Care | $21,584,977 |
Management and Operations | $19,959,146 |
Treatment | $9,701,038 |
Testing | $8,633,346 |
Budget Codes
OHSS: Health Systems Strengthening | $43,641,365 |
HVSI: Strategic Information | $26,571,737 |
HVOP: Sexual Prevention: Other Sexual Prevention | $21,579,045 |
HVMS: Management and Operations | $19,959,146 |
HBHC: Care: Adult Care and Support | $13,345,841 |
HTXS: Treatment: Adult Treatment | $9,194,543 |
HVCT: Testing: HIV Testing and Counseling | $8,633,346 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $6,864,148 |
HLAB: Laboratory Infrastructure | $6,404,614 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $6,215,209 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $5,203,396 |
HKID: Care: Orphans and Vulnerable Children | $4,227,083 |
HVTB: Care: TB/HIV | $3,670,020 |
HMBL: Biomedical Prevention: Blood Safety | $2,773,679 |
PDTX: Treatment: Pediatric Treatment | $483,018 |
PDCS: Care: Pediatric Care and Support | $342,033 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$82,191,898
Countries/Regions
FHI 360:
$20,837,928
Countries/Regions
USG Aggregated Agencies:
$15,691,183
Countries/Regions
Voluntary Health Services:
$8,030,000
Countries/Regions